{"ModuleTitle": "Company Description", "CompanyName": "Regeneron Pharmaceuticals, Inc.", "Symbol": "REGN", "Address": "777 OLD SAW MILL RIVER ROAD, TARRYTOWN, New York, 10591, United States of America", "Phone": "9148477000", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "This Annual Report on Form 10-K contains forward-looking statements that involve\r\nrisks and uncertainties relating to future events and the future performance of\r\nRegeneron Pharmaceuticals, Inc. (where applicable, together with its\r\nsubsidiaries, \"Regeneron,\" \"Company,\" \"we,\" \"us,\" and \"our\"), and actual events\r\nor results may differ materially from these forward-looking statements. Words\r\nsuch as \"anticipate,\" \"expect,\" \"intend,\" \"plan,\" \"believe,\" \"seek,\" \"estimate,\"\r\nvariations of such words, and similar expressions are intended to identify such\r\nforward-looking statements, although not all forward-looking statements contain\r\nthese identifying words.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f07%2f0001532176-20-000008.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "George Damis Yancopoulos", "title": "Co-President, Director & Chief Scientific Officer"}, {"name": "Leonard S. Schleifer", "title": "Co-President, Chief Executive Officer & Director"}, {"name": "Neil Stahl", "title": "Executive VP-Research & Development"}, {"name": "Robert E. Landry", "title": "Chief Financial Officer & Executive VP-Finance"}], "Number_of_employees": ["8,100"], "Subsidiaries": ["NO INFO"]}